Tectonic Therapeutic, Inc. (TECX)
NASDAQ: TECX · Real-Time Price · USD
19.92
-1.06 (-5.05%)
At close: Dec 5, 2025, 4:00 PM EST
19.88
-0.04 (-0.20%)
After-hours: Dec 5, 2025, 5:55 PM EST

Tectonic Therapeutic Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2014 2013
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '14 2013
Revenue
-----0.14
Upgrade
Revenue Growth (YoY)
-----2.13%
Upgrade
Gross Profit
-----0.14
Upgrade
Selling, General & Admin
20.2116.657.687.184.63-
Upgrade
Research & Development
56.341.3636.9725.6510.98-
Upgrade
Operating Expenses
76.5158.0244.6532.8315.61-
Upgrade
Operating Income
-76.51-58.02-44.65-32.83-15.61-
Upgrade
Interest Expense
-0.07-0.11-0.15-0.14-0.45-
Upgrade
Interest & Investment Income
10.474.260.580.15--
Upgrade
Other Non Operating Income (Expenses)
-0.21-4.121.40.658.1-
Upgrade
EBT Excluding Unusual Items
-66.32-57.98-42.82-32.18-7.96-
Upgrade
Other Unusual Items
-----0.97-
Upgrade
Pretax Income
-66.32-57.98-42.82-32.18-8.93-
Upgrade
Earnings From Continuing Operations
--57.98-42.82-32.18-8.93-
Upgrade
Net Income
-67.3-57.98-42.82-32.18-8.930.01
Upgrade
Net Income to Common
-67.3-57.98-42.82-32.18-8.93-
Upgrade
Shares Outstanding (Basic)
17813--
Upgrade
Shares Outstanding (Diluted)
17813--
Upgrade
Shares Change (YoY)
239.27%569.30%-49.78%---
Upgrade
EPS (Basic)
-3.88-6.83-33.76-12.74--
Upgrade
EPS (Diluted)
-3.88-6.83-33.76-12.74--
Upgrade
Free Cash Flow
-62.65-59.24-40.96-29.73-14.58-
Upgrade
Free Cash Flow Per Share
-3.61-6.98-32.29-11.77--
Upgrade
Gross Margin
-----100.00%
Upgrade
EBITDA
-74.96-56.37-43.17-31.82-15.25-
Upgrade
D&A For EBITDA
1.551.651.481.010.36-
Upgrade
EBIT
-76.51-58.02-44.65-32.83-15.61-
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q